NATURE JOURNALS' SELECTION

ADVERTISEMENT

Monoclonal antibodies inhibit prion replication and delay the development of prion disease FREE

Anthony R. White, Perry Enever, Mourad Tayebi, Rosey Mushens, Jackie Linehan, Sebastian Brandner, David Anstee, John Collinge & Simon Hawke

Nature 422, 80-83 (2003)

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Hyun-Soo Cho, Karen Mason, Kasra X. Ramyar, Ann Marie Stanley, Sandra B. Gabelli, Dan W. Denney & Daniel J. Leahy

Nature 421, 756-760 (2003)

Genetic, cellular and immune approaches to disease therapy: past and future

Gary J. Nabel

Nature Medicine 10, 135-141 (2004)

4-1BB-mediated immunotherapy of rheumatoid arthritis FREE

Su K. Seo, Jae H. Choi, Young H. Kim, Woo J. Kang, Hye Y. Park, Jae H. Suh, Beom K. Choi, Dass S. Vinay & Byoung S. Kwon

Nature Medicine 10, 1088-1094(2004)

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120

Ronald S. Veazey, Robin J. Shattock, Melissa Pope, J. Christian Kirijan, Jennifer Jones, Qinxue Hu, Tom Ketas, Preston A. Marx, Per Johan Klasse, Dennis R. Burton & John P. Moore

Nature Medicine 9, 343-346 (2003)

Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade

Nicola J. Monk, Roseanna E. G. Hargreaves, James E. Marsh, Conrad A. Farrar, Steven H. Sacks, Maggie Millrain, Elizabeth Simpson, Julian Dyson & Stipo Jurcevic

Nature Medicine 9, 1275-1280 (2003)

César Milstein, the father of modern immunology

Timothy A. Springer

Nature Immunology 3, 501-503 (2002)

HIV vaccine design and the neutralizing antibody problem FREE

Dennis R. Burton, Ronald C. Desrosiers, Robert W. Doms, Wayne C. Koff, Peter D. Kwong, John P. Moore, Gary J. Nabel, Joseph Sodroski, Ian A. Wilson & Richard T. Wyatt

Nature Immunology 5, 233-236 (2004)

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86

Ciriana Orabona, Ursula Grohmann, Maria Laura Belladonna, Francesca Fallarino, Carmine Vacca, Roberta Bianchi, Silvia Bozza, Claudia Volpi, Benoît L Salomon, Maria Cristina Fioretti, Luigina Romani & Paolo Puccetti

Nature Immunology 5, 1134-1142 (2004)

Improving the efficacy of antibody-based cancer therapies

Paul Carter

Nature Reviews Cancer 1, 118-129 (2001)

Ligand-targeted therapeutics in anticancer therapy FREE

Theresa M. Allen

Nature Reviews Cancer 2, 750-763 (2002)

Human antibody-Fc receptor interactions illuminated by crystal structures FREE

Jenny M. Woof & Dennis R. Burton

Nature Reviews Immunology 4, 89-99 (2004)

Monoclonal antibodies: the story of a discovery that revolutionized science and medicine FREE

Sefik S. Alkan

Nature Reviews Immunology 4, 153-156 (2004)

Antibodies, viruses and vaccines

Dennis R. Burton

Nature Reviews Immunology 2, 706-713 (2002)

Antibody-targeted radiation cancer therapy FREE

Diane E. Milenic, Erik D. Brady & Martin W. Brechbiel

Nature Reviews Drug Discovery 3, 488-499 (2004)

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

Ole Henrik Brekke & Inger Sandlie

Nature Reviews Drug Discovery 2, 52-62 (2003)

Case history: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Napoleone Ferrara, Kenneth J. Hillan, Hans-Peter Gerber & William Novotny

Nature Reviews Drug Discovery 3, 391-400 (2004)

Extra navigation

.

SUPPORTED BY:

ADVERTISEMENT